We're experimenting and would love to hear from you!

In today's episode of 'Discover Daily', we explore the healthcare bill, H.R. 206, thats making waves in Congress as it proposes to allow AI systems to prescribe medications. The Healthy Technology Act of 2023 could revolutionize healthcare delivery by qualifying AI as prescribing practitioners, sparking intense debates over patient safety, algorithmic bias, and the future of medical decision-making in an AI-powered healthcare system.

We then turn to Kansas, a state grappling with the largest tuberculosis outbreak in U.S. history since the 1950s, with 67 active cases and 79 latent infections primarily concentrated in Wyandotte and Johnson counties. While health officials emphasize that the risk to the general public remains low, the outbreak has prompted an aggressive containment strategy including free testing, enhanced contact tracing, and collaboration with CDC experts.

Then in tech industry developments, Microsoft CEO Satya Nadella warns about the Jevons Paradox in AI, as Chinese startup DeepSeek introduces groundbreaking efficient models. Nadella suggests that improved efficiency could paradoxically lead to unprecedented levels of AI consumption, potentially reshaping the entire tech industry and raising crucial questions about sustainability and energy usage in the AI sector.

From Perplexity's Discover Feed:

https://www.perplexity.ai/page/ai-prescription-bill-proposed-qjHVQk3ORxCsufj4FODmGw

https://www.perplexity.ai/page/tb-outbreak-hits-kansas-QtMgE.T8S0GP3Esmk0sGVQ 

https://www.perplexity.ai/page/nadella-predicts-jevons-parado-lXTDyvFjTuaoa1p5Jp3OuA 

Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you’re interested in.

Take the world's knowledge with you anywhere. Available on iOS and Android

Join our growing Discord community for the latest updates and exclusive content.

Follow us on:

• Instagram
• Threads
• X (Twitter)
• YouTube
• Linkedin